Article
A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer
31 Jul 2019
Abstract excerpt
Background: The current staging system is imprecise for prognostic prediction of early-stage non–small cell lung cancer (NSCLC). This study aimed to develop a robust prognostic signature for early-stage NSCLC, allowing classification of patients with a high risk of poor outcome and specific treatment decision. Method: In the present study, a comprehensive genome-wide profiling analysis was conducted using a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
